https://www.selleckchem.com/pr....oducts/asciminib-abl
The coronavirus disease (COVID-19) pandemic has presented challenges in the care of patients with chronic diseases. We identified the challenges faced by Chinese patients with Duchenne muscular dystrophy (DMD) during the pandemic. An online cross-sectional survey was conducted between March 27 and June 30, 2021. Of the 2105 valid questionnaire responses, 2,056 patients were from non-lockdown areas. In these areas, 42.8% reduced outside daily activities, 49.4% reduced rehabilitation service use, 39.7% postponed regular follow-up
Мне нравится
Комментарий
Перепост
